What are Common Misconceptions in Dialysis Patient Care? Anemia and Iron Management

被引：7
作者：
Besarab, Anatole [1 ]
机构：
[1] Henry Ford Hosp, Div Nephrol & Hypertens, Dept Med, Detroit, MI 48202 USA
来源：
SEMINARS IN DIALYSIS | 2011年 / 24卷 / 05期
关键词：
RED-CELL APLASIA; HEMOGLOBIN VARIABILITY; HEMODIALYSIS-PATIENTS; SERUM FERRITIN; EPOETIN-ALPHA; ERYTHROPOIETIN; DEFICIENCY; MORTALITY; HYPORESPONSIVENESS; THROMBOCYTOSIS;
D O I：
10.1111/j.1525-139X.2011.00983.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：498 / 503
页数：6
相关论文
共 58 条
[1]  
ALI M, 1982, LANCET, V1, P652
[2]  
[Anonymous], FDA ADV COMM BRIEF D
[3]   Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD [J].
Babitt, Jodie L. ;
Lin, Herbert Y. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) :726-741
[4]   Hemoglobin variability in epoetin-treated hemodialysis patients [J].
Berns, JS ;
Elzein, H ;
Lynn, RI ;
Fishbane, S ;
Meisels, IS ;
DeOreo, PB .
KIDNEY INTERNATIONAL, 2003, 64 (04) :1514-1521
[5]   A study of parenteral iron regimens in hemodialysis patients [J].
Besarab, A ;
Kaiser, JW ;
Frinak, S .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (01) :21-28
[6]  
Besarab A, 2000, J AM SOC NEPHROL, V11, P530, DOI 10.1681/ASN.V113530
[7]   The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin [J].
Besarab, A ;
Bolton, WK ;
Browne, JK ;
Egrie, JC ;
Nissenson, AR ;
Okamoto, DM ;
Schwab, SJ ;
Goodkin, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :584-590
[8]   Iron Metabolism, Iron Deficiency, Thrombocytosis, and the Cardiorenal Anemia Syndrome [J].
Besarab, Anatole ;
Hoerl, Walter Hermann ;
Silverberg, Donald .
ONCOLOGIST, 2009, 14 :22-33
[9]   Amino acid sequence homology of thrombopoietin and erythropoietin may explain thrombocytosis in children with iron deficiency anemia [J].
Bilic, E ;
Bilic, E .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (08) :675-676
[10]   Continuous intravenous sodium ferric gluconate improves efficacy in the maintenance phase of EPOrHu administration in hemodialysis patients [J].
Bolaños, L ;
Castro, P ;
Falcón, TG ;
Mouzo, R ;
Varela, JM .
AMERICAN JOURNAL OF NEPHROLOGY, 2002, 22 (01) :67-72
123456